|
Pharma Marketing Glossary TM reflects the experience and knowledge of contributors who are experts in the field of pharmaceutical marketing. Included along with formal definitions are unique insights and quotes from these experts and other sources.
We accept advertising relevant to the interests of our members. For more information, see: Operated by: VirSci Corporation PO Box 760 Newtown, PA 18940 215-504-4164 215-504-5739 (FAX) E-mail: infovirsci@virsci.com |
![]()
Advertising Information | FAQs | About Us | Contact Us | Privacy Policy
The Pharma Marketing Glossary
Definition An alternative way for drug companies to provide risk information about a drug in a broadcast ad. Drug companies generally must include all of a drug's risk information in a product claim ad. In print ads, they usually do this in the "brief summary." This brief summary would take many minutes to read or scroll down a TV screen. The law allows broadcast ads to include only the most important risk information if the ads tell viewers or listeners how to get the full FDA-approved prescribing information, which has all the drug's risks. To meet the "adequate provision" requirement, the broadcast ad must provide ways to find the drug's FDA-approved prescribing information.
Return to Pharma Marketing Glossary Index Page to select another term or click on a letter below to view a list of terms beginning with that letter.
Submit a Definition to The Pharma Marketing Glossary
If you would like to submit an alternative definition of this term or one for a new term, or if you have more information that relates to this term, including opinions, illustrations of how the term is used or misused, etc., please submit your contribution using The Pharma Marketing Glossary Entry Form. Thank you.
Pharma Marketing News |
Subscribe |
Discussion Forums |
Roundtable |
Podcasts |
Blog
© 2004-2009. VirSci Corporation.
All rights reserved.
|
|